BioVie Inc.
BioVie Inc. (BIVI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bivi · stock forecast · 5 analysts (3M) · FMP · updated May 12, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.67
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.75 | ↑ 5.00% |
1-day model range: $1.74–$1.77. Peak: $1.77 (+5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BIVI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-11-30 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-08-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-07-18 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-05-17 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-05-17 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2023-02-14 | Oppenheimer | Maintains | Outperform→Outperform |
| 2022-09-28 | EF Hutton | Maintains | Buy→Buy |
| 2022-07-22 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2022-03-17 | EF Hutton | Maintains | Buy→Buy |
| 2022-03-15 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on BioVie Inc. (BIVI) stock. Of the recent 12 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover BIVI.
Analyst Recommendation Trends
BIVI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$-1M
↓ 104.7% YoY
Revenue Next Year
$-1M
↑ 0.0% YoY
EPS This Year
$-101.00
EPS Next Year
$-12.12
↓ 88.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast BIVI EPS of $-101.00 for the current fiscal year, based on estimates from 1 analysts. The BIVI revenue forecast is $-1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BIVI stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BIVI price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The BIVI short-term stock prediction for tomorrow is $1.75 (+5.00%).
BioVie Inc. trades on NASDAQ under the ticker BIVI. The BIVI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BIVI forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month BIVI price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.67.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.